Clarus Therapeutics Holdings, Inc.

Ownership Transactions Reported by 14 Insiders

Industry
Biological Products, (No Diagnostic Substances)
Location
355 S. Grand Avenue, Suite 1450, Los Angeles, CA

There are no Buy or Sell transactions made by insiders since 12/23/2023

Clarus Therapeutics Holdings, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Kimberly Murphy Director Jun 7, 2022
H.I.G. Ventures - Clarus, LLC 10%+ Owner Sep 9, 2021
Ffi Fund Ltd 10%+ Owner Sep 17, 2021
Thomas Mcnerney & Partners Lp 10%+ Owner Apr 20, 2022
Mark A. Sr Prygocki Director Jun 7, 2022
Joseph Hernandez Director Jun 7, 2022
Elizabeth Cermak Director Jun 7, 2022
Steven A. Bourne Chief Administrative Officer Dec 11, 2021
Robert E. Dudley Chief Executive Officer, Director Dec 12, 2021
Alex Zisson Director, 10%+ Owner Sep 9, 2021
Richard D. Peterson Chief Financial Officer Dec 11, 2021
Frank Jaeger Chief Commercial Officer Dec 11, 2021
John Kenneth Amory Director Jun 7, 2022
CBC SPVI Ltd 10%+ Owner Sep 9, 2021

Recent Insider Transactions by Companies or Individuals for Clarus Therapeutics Holdings, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.